• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CXCL4 和 CXCL4L1 在癌症中的作用。

CXCL4 and CXCL4L1 in cancer.

机构信息

KU Leuven, University of Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Molecular Immunology, B-3000 Leuven, Belgium.

KU Leuven, University of Leuven, Department of Microbiology and Immunology, Rega Institute for Medical Research, Laboratory of Molecular Immunology, B-3000 Leuven, Belgium.

出版信息

Cytokine. 2018 Sep;109:65-71. doi: 10.1016/j.cyto.2018.02.022.

DOI:10.1016/j.cyto.2018.02.022
PMID:29903575
Abstract

Chemokines regulate leukocyte migration during physiological and pathological conditions. It is currently accepted that these chemotactic cytokines are also important in the development and progression of cancer. CXCL4 and its non-allelic variant CXCL4L1 are two platelet-associated chemokines that have been attributed anti-tumoral activity as a result of their angiostatic potential and the chemotactic activity for anti-tumoral leukocytes. Here we review the role of CXCL4 and CXCL4L1 in cancer, the use of both chemokines as cancer biomarkers and discuss some possible therapeutic opportunities.

摘要

趋化因子在生理和病理条件下调节白细胞的迁移。目前人们认为,这些趋化细胞因子在癌症的发生和发展中也很重要。CXCL4 和其非等位基因变体 CXCL4L1 是两种与血小板相关的趋化因子,由于其具有抗血管生成潜力和趋化抗肿瘤白细胞的活性,被认为具有抗肿瘤活性。在这里,我们回顾了 CXCL4 和 CXCL4L1 在癌症中的作用、这两种趋化因子作为癌症生物标志物的应用,并讨论了一些可能的治疗机会。

相似文献

1
CXCL4 and CXCL4L1 in cancer.CXCL4 和 CXCL4L1 在癌症中的作用。
Cytokine. 2018 Sep;109:65-71. doi: 10.1016/j.cyto.2018.02.022.
2
Angiostatic, tumor inflammatory and anti-tumor effects of CXCL4(47-70) and CXCL4L1(47-70) in an EGF-dependent breast cancer model.在表皮生长因子依赖的乳腺癌模型中,CXCL4(47 - 70)和CXCL4L1(47 - 70)的血管生成抑制、肿瘤炎症及抗肿瘤作用
Oncotarget. 2014 Nov 15;5(21):10916-33. doi: 10.18632/oncotarget.2538.
3
CXCL4L1 inhibits angiogenesis and induces undirected endothelial cell migration without affecting endothelial cell proliferation and monocyte recruitment.CXCL4L1 抑制血管生成,并诱导无定向的内皮细胞迁移,而不影响内皮细胞增殖和单核细胞募集。
J Thromb Haemost. 2011 Jan;9(1):209-19. doi: 10.1111/j.1538-7836.2010.04119.x.
4
CXCL4L1 and CXCL4 signaling in human lymphatic and microvascular endothelial cells and activated lymphocytes: involvement of mitogen-activated protein (MAP) kinases, Src and p70S6 kinase.CXCL4L1 和 CXCL4 在人淋巴管和微血管内皮细胞及活化淋巴细胞中的信号转导:丝裂原活化蛋白(MAP)激酶、Src 和 p70S6 激酶的参与。
Angiogenesis. 2014 Jul;17(3):631-40. doi: 10.1007/s10456-014-9417-6. Epub 2014 Jan 28.
5
The COOH-terminal peptide of platelet factor-4 variant (CXCL4L1/PF-4var47-70) strongly inhibits angiogenesis and suppresses B16 melanoma growth in vivo.血小板因子 4 变体(CXCL4L1/PF-4var47-70)的羧基末端肽强烈抑制血管生成,并在体内抑制 B16 黑色素瘤的生长。
Mol Cancer Res. 2010 Mar;8(3):322-34. doi: 10.1158/1541-7786.MCR-09-0176. Epub 2010 Mar 9.
6
Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis.血小板因子-4变体趋化因子CXCL4L1通过抑制血管生成来抑制黑色素瘤和肺癌的生长及转移。
Cancer Res. 2007 Jun 15;67(12):5940-8. doi: 10.1158/0008-5472.CAN-06-4682.
7
The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer.CXC 趋化因子血小板因子 4(CXCL4/PF-4)及其变体(CXCL4L1/PF-4var)在炎症、血管生成和癌症中的作用。
Cytokine Growth Factor Rev. 2011 Feb;22(1):1-18. doi: 10.1016/j.cytogfr.2010.10.011. Epub 2010 Nov 26.
8
Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3.CXC 趋化因子 CXCL4L1(血小板因子-4 变体)的血管生成和趋化活性由 CXCR3 介导。
Blood. 2011 Jan 13;117(2):480-8. doi: 10.1182/blood-2009-11-253591. Epub 2010 Oct 27.
9
Elevated expression of platelet-derived chemokines in patients with antiphospholipid syndrome.抗磷脂综合征患者血小板衍生趋化因子的表达升高。
J Autoimmun. 2015 Dec;65:30-7. doi: 10.1016/j.jaut.2015.08.001. Epub 2015 Aug 15.
10
Stimulation of angiostatic platelet factor-4 variant (CXCL4L1/PF-4var) versus inhibition of angiogenic granulocyte chemotactic protein-2 (CXCL6/GCP-2) in normal and tumoral mesenchymal cells.在正常和肿瘤间充质细胞中,血管抑制性血小板因子4变体(CXCL4L1/PF-4var)的刺激与血管生成性粒细胞趋化蛋白2(CXCL6/GCP-2)的抑制作用
J Leukoc Biol. 2007 Dec;82(6):1519-30. doi: 10.1189/jlb.0407206. Epub 2007 Sep 7.

引用本文的文献

1
Platelets in Hepatocellular Carcinoma-From Pathogenesis to Targeted Therapy.肝细胞癌中的血小板——从发病机制到靶向治疗
Cancers (Basel). 2025 Jul 18;17(14):2391. doi: 10.3390/cancers17142391.
2
SPI1 triggers the formation of neutrophil extracellular traps in multiple sclerosis through CXCL4.SPI1通过CXCL4触发多发性硬化症中中性粒细胞胞外陷阱的形成。
J Mol Histol. 2025 Jul 9;56(4):219. doi: 10.1007/s10735-025-10516-1.
3
A novel gene signature for forecasting time to next relapse in multiple sclerosis using peripheral blood mononuclear cells.
一种利用外周血单个核细胞预测多发性硬化症下次复发时间的新型基因特征。
BMC Neurol. 2025 Jul 1;25(1):261. doi: 10.1186/s12883-025-04231-3.
4
CXCL Gene Clusters Regulated by Enhancer-Mediated DNA Looping Alteration in Pancreatic Cancer Cells.CXCL基因簇在胰腺癌细胞中受增强子介导的DNA环化改变调控。
J Cell Mol Med. 2025 Apr;29(7):e70538. doi: 10.1111/jcmm.70538.
5
The Role of CXCL4 in Systemic Sclerosis: DAMP, Auto-Antigen and Biomarker.CXCL4在系统性硬化症中的作用:损伤相关分子模式、自身抗原及生物标志物
Int J Mol Sci. 2025 Mar 7;26(6):2421. doi: 10.3390/ijms26062421.
6
Senolytic agent ABT-263 mitigates low- and high-LET radiation-induced gastrointestinal cancer development in mice.衰老细胞裂解剂ABT-263减轻小鼠低线性能量传递和高线性能量传递辐射诱导的胃肠道癌症发生。
Aging (Albany NY). 2025 Jan 8;17(1):97-115. doi: 10.18632/aging.206183.
7
C5aR1-positive adipocytes mediate non-shivering thermogenesis in neonatal mice.C5aR1阳性脂肪细胞介导新生小鼠的非寒战产热。
iScience. 2024 Oct 28;27(12):111261. doi: 10.1016/j.isci.2024.111261. eCollection 2024 Dec 20.
8
New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine.新的遗传和表观遗传对趋化因子系统的深入了解:最新发现有助于朝着精准医学迈进。
Cell Mol Immunol. 2023 Jul;20(7):739-776. doi: 10.1038/s41423-023-01032-x. Epub 2023 May 17.
9
Targeting CXCL9/10/11-CXCR3 axis: an important component of tumor-promoting and antitumor immunity.靶向 CXCL9/10/11-CXCR3 轴:促进肿瘤和抗肿瘤免疫的重要组成部分。
Clin Transl Oncol. 2023 Aug;25(8):2306-2320. doi: 10.1007/s12094-023-03126-4. Epub 2023 Apr 19.
10
CXCL4L1 May Help Differentiate Benign from Malignant Pulmonary Lesions and Predicts Prognosis of Patients with Lung Cancer.CXCL4L1 可能有助于鉴别肺部良性与恶性病变,并预测肺癌患者的预后。
Cancer Manag Res. 2022 Jun 7;14:1903-1910. doi: 10.2147/CMAR.S352217. eCollection 2022.